Ben Salah, A., Buffet, P. A., Morizot, G., Ben Massoud, N., Zâatour, A., Ben Alaya, N., . . . Grögl, M. (2009). WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. Public Library of Science.
Styl ChicagoBen Salah, Afif, et al. WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania Major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. Public Library of Science, 2009.
Citace podle MLABen Salah, Afif, et al. WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania Major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. Public Library of Science, 2009.